Published in Antimicrob Agents Chemother on December 01, 2000
ISCR elements: novel gene-capturing systems of the 21st century? Microbiol Mol Biol Rev (2006) 5.50
Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev (2003) 3.72
Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob Agents Chemother (2003) 3.22
Acquired antibiotic resistance genes: an overview. Front Microbiol (2011) 2.80
Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides. Antimicrob Agents Chemother (2004) 2.65
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides. Antimicrob Agents Chemother (2007) 2.23
Novel plasmid-mediated 16S rRNA methylase, RmtC, found in a proteus mirabilis isolate demonstrating extraordinary high-level resistance against various aminoglycosides. Antimicrob Agents Chemother (2006) 1.98
Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Rev Pharmacoecon Outcomes Res (2010) 1.52
RmtF, a new member of the aminoglycoside resistance 16S rRNA N7 G1405 methyltransferase family. Antimicrob Agents Chemother (2012) 1.49
Genetic environments of the rmtA gene in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother (2004) 1.47
Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry. EMBO J (2002) 1.46
The crystal structures of substrate and nucleotide complexes of Enterococcus faecium aminoglycoside-2''-phosphotransferase-IIa [APH(2'')-IIa] provide insights into substrate selectivity in the APH(2'') subfamily. J Bacteriol (2009) 1.27
Fluorescent pyrimidine ribonucleotide: synthesis, enzymatic incorporation, and utilization. J Am Chem Soc (2007) 1.23
Binding of neomycin-class aminoglycoside antibiotics to mutant ribosomes with alterations in the A site of 16S rRNA. Antimicrob Agents Chemother (2006) 1.15
Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessus. J Antimicrob Chemother (2011) 1.15
30S ribosomal subunit assembly is a target for inhibition by aminoglycosides in Escherichia coli. Antimicrob Agents Chemother (2002) 1.15
Analysis of the contribution of individual substituents in 4,6-aminoglycoside-ribosome interaction. Antimicrob Agents Chemother (2005) 1.15
16S ribosomal RNA methylase RmtD produced by Klebsiella pneumoniae in Brazil. J Antimicrob Chemother (2008) 1.12
Systematic analysis of a conserved region of the aminoglycoside 6'-N-acetyltransferase type Ib. Antimicrob Agents Chemother (2001) 1.08
High prevalence of plasmid-mediated 16S rRNA methylase gene rmtB among Escherichia coli clinical isolates from a Chinese teaching hospital. BMC Infect Dis (2010) 1.06
Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors. Antimicrob Agents Chemother (2005) 1.06
Panel of Bacillus subtilis reporter strains indicative of various modes of action. Antimicrob Agents Chemother (2004) 1.05
Aminoglycosides decrease glutathione peroxidase-1 activity by interfering with selenocysteine incorporation. J Biol Chem (2005) 1.03
Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt. PLoS One (2011) 1.02
Plasmid-mediated 16S rRNA methylases in aminoglycoside-resistant Enterobacteriaceae isolates in Shanghai, China. Antimicrob Agents Chemother (2008) 1.02
External guide sequences targeting the aac(6')-Ib mRNA induce inhibition of amikacin resistance. Antimicrob Agents Chemother (2007) 1.01
Antimony-resistant clinical isolates of Leishmania donovani are susceptible to paromomycin and sitamaquine. Antimicrob Agents Chemother (2011) 0.97
Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance by antisense oligodeoxynucleotides. Antimicrob Agents Chemother (2003) 0.97
Tobramycin at subinhibitory concentration inhibits the RhlI/R quorum sensing system in a Pseudomonas aeruginosa environmental isolate. BMC Infect Dis (2010) 0.96
6''-Thioether tobramycin analogues: towards selective targeting of bacterial membranes. Angew Chem Int Ed Engl (2012) 0.96
Structural basis for the methylation of A1408 in 16S rRNA by a panaminoglycoside resistance methyltransferase NpmA from a clinical isolate and analysis of the NpmA interactions with the 30S ribosomal subunit. Nucleic Acids Res (2010) 0.95
Surprising alteration of antibacterial activity of 5"-modified neomycin against resistant bacteria. J Med Chem (2008) 0.95
The aminoglycoside 6'-N-acetyltransferase type Ib encoded by Tn1331 is evenly distributed within the cell's cytoplasm. Antimicrob Agents Chemother (2003) 0.93
Evolution and recombination of the plasmidic qnr alleles. J Mol Evol (2008) 0.89
Complete thermodynamic characterization of the multiple protonation equilibria of the aminoglycoside antibiotic paromomycin: a calorimetric and natural abundance 15N NMR study. Biophys J (2005) 0.89
Inhibitors of aminoglycoside resistance activated in cells. ACS Chem Biol (2012) 0.85
A high throughput multiplex PCR assay for simultaneous detection of seven aminoglycoside-resistance genes in Enterobacteriaceae. BMC Microbiol (2013) 0.84
Prevalence of 16S rRNA methylase genes among β-lactamase-producing Enterobacteriaceae clinical isolates in Saudi Arabia. Libyan J Med (2014) 0.82
Aminoglycoside inhibition of Staphylococcus aureus biofilm formation is nutrient dependent. J Med Microbiol (2014) 0.81
From penicillin-streptomycin to amikacin-vancomycin: antibiotic decontamination of cardiovascular homografts in Singapore. PLoS One (2012) 0.81
Molecular epidemiology of aminoglycosides resistance on Klebsiella pneumonia in a hospital in China. Int J Clin Exp Med (2015) 0.81
Global epigenetic changes induced by SWI2/SNF2 inhibitors characterize neomycin-resistant mammalian cells. PLoS One (2012) 0.80
Purification, crystallization and preliminary X-ray analysis of Enterococcus casseliflavus aminoglycoside-2''-phosphotransferase-IVa. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.79
Genome-scale resources for Thermoanaerobacterium saccharolyticum. BMC Syst Biol (2015) 0.79
Aminoglycoside-Induced Premature Stop Codon Read-Through of Mucopolysaccharidosis Type I Patient Q70X and W402X Mutations in Cultured Cells. JIMD Rep (2013) 0.78
Transient kinetics of aminoglycoside phosphotransferase(3')-IIIa reveals a potential drug target in the antibiotic resistance mechanism. FEBS Lett (2012) 0.78
Genomic analysis reveals distinct concentration-dependent evolutionary trajectories for antibiotic resistance in Escherichia coli. DNA Res (2014) 0.77
Evaluation of RNA-binding specificity of aminoglycosides with DNA microarrays. Proc Natl Acad Sci U S A (2006) 0.77
Direct observation of aminoglycoside-RNA binding by localized surface plasmon resonance spectroscopy. Anal Chem (2013) 0.76
Novel Escherichia coli RF1 mutants with decreased translation termination activity and increased sensitivity to the cytotoxic effect of the bacterial toxins Kid and RelE. Mol Microbiol (2008) 0.76
Biomaterials with Antibacterial and Osteoinductive Properties to Repair Infected Bone Defects. Int J Mol Sci (2016) 0.76
Selective condensation of DNA by aminoglycoside antibiotics. Eur Biophys J (2015) 0.75
Detection and Quantification of Ribosome Inhibition by Aminoglycoside Antibiotics in Living Bacteria Using an Orthogonal Ribosome-Controlled Fluorescent Reporter. ACS Chem Biol (2015) 0.75
Study of aminoglycoside resistance genes in enterococcus and salmonella strains isolated from ilam and milad hospitals, iran. Jundishapur J Microbiol (2015) 0.75
An Escherichia coli strain, PGB01, isolated from feral pigeon Faeces, thermally fit to survive in pigeon, shows high level resistance to trimethoprim. PLoS One (2015) 0.75
Comparative genomic analysis of Klebsiella pneumonia (LCT-KP214) and a mutant strain (LCT-KP289) obtained after spaceflight. BMC Genomics (2014) 0.75
Evaluation of the Interaction between the Poincianella pyramidalis (Tul.) LP Queiroz Extract and Antimicrobials Using Biological and Analytical Models. PLoS One (2016) 0.75
Synthesis and antibacterial activity of pyranmycin derivatives with N-1 and O-6 modifications. Bioorg Med Chem (2007) 0.75
In vivo Host Environment Alters Pseudomonas aeruginosa Susceptibility to Aminoglycoside Antibiotics. Front Cell Infect Microbiol (2017) 0.75
Modeling intraocular bacterial infections. Prog Retin Eye Res (2016) 0.75
Multidrug Intrinsic Resistance Factors in Staphylococcus aureus Identified by Profiling Fitness within High-Diversity Transposon Libraries. MBio (2016) 0.75
Cloning, expression, purification, crystallization and X-ray crystallographic analysis of Rv3168 from Mycobacterium tuberculosis H37Rv. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.75
Asymmetric stereodivergent strategy towards aminocyclitols. Chemistry (2014) 0.75
Substrate Recognition and Modification by a Pathogen-Associated Aminoglycoside Resistance 16S rRNA Methyltransferase. Antimicrob Agents Chemother (2017) 0.75
Function and origin of mistranslation in distinct cellular contexts. Crit Rev Biochem Mol Biol (2017) 0.75
Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem. PLoS One (2017) 0.75
X-ray crystal structures of 70S ribosome functional complexes. Science (1999) 10.51
Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev (1993) 9.38
Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature (1987) 8.96
Self-splicing of group I introns. Annu Rev Biochem (1990) 6.36
Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science (1996) 3.94
Ribosomal RNA and translation. Annu Rev Biochem (1991) 3.83
Mechanism of bactericidal action of aminoglycosides. Microbiol Rev (1987) 3.39
Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother (1999) 3.15
Aminoglycosides: activity and resistance. Antimicrob Agents Chemother (1999) 3.11
Sites of action of two ribosomal RNA methylases responsible for resistance to aminoglycosides. J Mol Biol (1987) 2.99
Antibiotic inhibition of group I ribozyme function. Nature (1991) 2.44
Structure of an enzyme required for aminoglycoside antibiotic resistance reveals homology to eukaryotic protein kinases. Cell (1997) 2.33
Structural origins of gentamicin antibiotic action. EMBO J (1998) 2.20
Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA. J Mol Biol (1998) 2.06
RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide. J Mol Biol (1996) 1.92
Basis for prokaryotic specificity of action of aminoglycoside antibiotics. EMBO J (1999) 1.91
Crystal structure of a GCN5-related N-acetyltransferase: Serratia marcescens aminoglycoside 3-N-acetyltransferase. Cell (1998) 1.90
Footprinting the sites of interaction of antibiotics with catalytic group I intron RNA. Science (1993) 1.90
Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA. J Mol Biol (1998) 1.77
Crystal structure of an aminoglycoside 6'-N-acetyltransferase: defining the GCN5-related N-acetyltransferase superfamily fold. Structure (1999) 1.69
Aminoglycoside-induced hearing loss in humans. Antimicrob Agents Chemother (1989) 1.63
Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America). Diagn Microbiol Infect Dis (1999) 1.50
Methylation of 16S ribosomal RNA and resistance to the aminoglycoside antibiotics gentamicin and kanamycin determined by DNA from the gentamicin-producer, Micromonospora purpurea. Mol Gen Genet (1985) 1.42
Structural investigation of the antibiotic and ATP-binding sites in kanamycin nucleotidyltransferase. Biochemistry (1995) 1.40
Enhanced RNA binding of dimerized aminoglycosides. Bioorg Med Chem (1999) 1.37
Solution structure of the tobramycin-RNA aptamer complex. Nat Struct Biol (1998) 1.37
Inhibition of the hammerhead ribozyme by neomycin. RNA (1995) 1.31
Deciphering RNA recognition: aminoglycoside binding to the hammerhead ribozyme. Chem Biol (1998) 1.26
Selective perturbation of G530 of 16 S rRNA by translational miscoding agents and a streptomycin-dependence mutation in protein S12. J Mol Biol (1994) 1.24
Prodigious substrate specificity of AAC(6')-APH(2"), an aminoglycoside antibiotic resistance determinant in enterococci and staphylococci. Chem Biol (1999) 1.20
Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics. J Mol Biol (1996) 1.17
The crystal structure of ribosomal protein L22 from Thermus thermophilus: insights into the mechanism of erythromycin resistance. Structure (1998) 1.16
Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance. J Am Chem Soc (1997) 1.16
Docking of cationic antibiotics to negatively charged pockets in RNA folds. J Med Chem (1999) 1.15
Novel mutation in 16S rRNA associated with streptomycin dependence in Mycobacterium tuberculosis. Antimicrob Agents Chemother (1995) 1.13
Molecular structure of kanamycin nucleotidyltransferase determined to 3.0-A resolution. Biochemistry (1993) 1.10
The binding site of a specific aminoglycoside binding RNA molecule. Biochemistry (1998) 1.09
Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme. Eur J Clin Microbiol Infect Dis (1999) 1.07
tRNA(Phe) binds aminoglycoside antibiotics. Bioorg Med Chem (1999) 0.96
Specificity in the binding of aminoglycosides to HIV-RRE RNA. Biochemistry (1999) 0.93
Mutations in ribosomal protein L10e confer resistance to the fungal-specific eukaryotic elongation factor 2 inhibitor sordarin. J Biol Chem (1999) 0.92
Saccharide-RNA recognition. Biopolymers (1998) 0.91
Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside. Clin Infect Dis (1992) 0.88
Recognition of aminoglycoside antibiotics by enterococcal-staphylococcal aminoglycoside 3'-phosphotransferase type IIIa: role of substrate amino groups. Antimicrob Agents Chemother (1996) 0.85
RNA-aminoglycoside antibiotic interactions: fluorescence detection of binding and conformational change. Bioorg Med Chem Lett (1999) 0.84
Kinship and diversification of bacterial penicillin-binding proteins and beta-lactamases. Antimicrob Agents Chemother (1998) 3.37
Matrix metalloproteinases: structures, evolution, and diversification. FASEB J (1998) 2.74
Critical involvement of a carbamylated lysine in catalytic function of class D beta-lactamases. Proc Natl Acad Sci U S A (2001) 2.21
Elucidation of the role of arginine-244 in the turnover processes of class A beta-lactamases. Biochemistry (1992) 1.96
Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei. Antimicrob Agents Chemother (1989) 1.93
Insights into class D beta-lactamases are revealed by the crystal structure of the OXA10 enzyme from Pseudomonas aeruginosa. Structure (2000) 1.84
Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J Biol Chem (1997) 1.81
Early treatment of premature infants with recombinant human erythropoietin. Pediatrics (1993) 1.65
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res (1995) 1.63
Transcatheter occlusion of patent ductus arteriosus with adjustable buttoned device. Initial clinical experience. Circulation (1993) 1.63
Osteoid osteoma: MR imaging versus CT. Radiology (1994) 1.59
How beta-lactamases have driven pharmaceutical drug discovery. From mechanistic knowledge to clinical circumvention. Adv Exp Med Biol (1998) 1.58
Substrate hydrolysis by matrix metalloproteinase-9. J Biol Chem (2001) 1.54
A structure-based analysis of the inhibition of class A beta-lactamases by sulbactam. Biochemistry (1994) 1.47
A 1.2-A snapshot of the final step of bacterial cell wall biosynthesis. Proc Natl Acad Sci U S A (2001) 1.46
Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1. J Biol Chem (2000) 1.43
Effects on substrate profile by mutational substitutions at positions 164 and 179 of the class A TEM(pUC19) beta-lactamase from Escherichia coli. J Biol Chem (1999) 1.39
[Continuing education and health work: a process under construction]. Educ Med Salud (1994) 1.39
Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase gene. Antimicrob Agents Chemother (1998) 1.38
Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome. Cell Mol Life Sci (2005) 1.38
Effects of Asp-179 mutations in TEMpUC19 beta-lactamase on susceptibility to beta-lactams. Antimicrob Agents Chemother (1995) 1.25
Follow-up results of transvenous occlusion of patent ductus arteriosus with the buttoned device. J Am Coll Cardiol (1999) 1.23
Aminoglycoside antibiotics. Structures, functions, and resistance. Adv Exp Med Biol (1998) 1.23
X-ray absorption studies of human matrix metalloproteinase-2 (MMP-2) bound to a highly selective mechanism-based inhibitor. comparison with the latent and active forms of the enzyme. J Biol Chem (2001) 1.21
Reversal of clavulanate resistance conferred by a Ser-244 mutant of TEM-1 beta-lactamase as a result of a second mutation (Arg to Ser at position 164) that enhances activity against ceftazidime. Antimicrob Agents Chemother (1994) 1.21
Serum concentrations of 25-hydroxyvitamin D in rickets of extremely premature infants. J Pediatr (1979) 1.15
Purification, characterization, and investigation of the mechanism of aminoglycoside 3'-phosphotransferase type Ia. Biochemistry (1995) 1.15
Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition. Drug Resist Updat (2001) 1.15
Tongue lesions in the pediatric population. Otolaryngol Head Neck Surg (2001) 1.13
Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. J Biol Chem (2000) 1.11
Purification and characterization of aminoglycoside 3'-phosphotransferase type IIa and kinetic comparison with a new mutant enzyme. Antimicrob Agents Chemother (1994) 1.05
Volvulus of the sigmoid colon in Brazil: a report of 230 cases. Dis Colon Rectum (1976) 1.05
Eosinophilic granuloma of the clivus: case report, follow-up of two previously reported cases, and review of the literature on cranial base eosinophilic granuloma. Neurosurgery (1997) 1.04
Reactions of Escherichia coli TEM beta-lactamase with cephalothin and with C10-dipeptidyl cephalosporin esters. J Biol Chem (1986) 1.03
Structural and mechanistic aspects of evolution of beta-lactamases and penicillin-binding proteins. Curr Pharm Des (1999) 1.03
Critical hydrogen bonding by serine 235 for cephalosporinase activity of TEM-1 beta-lactamase. Antimicrob Agents Chemother (1993) 1.02
X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid. Biochemistry (1999) 1.00
Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog. J Clin Invest (1977) 0.99
Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis. Neurology (2008) 0.99
Class C beta-lactamases operate at the diffusion limit for turnover of their preferred cephalosporin substrates. Antimicrob Agents Chemother (1999) 0.98
6-(hydroxyalkyl)penicillanates as probes for mechanisms of beta-lactamases. J Antibiot (Tokyo) (2000) 0.97
Subperiosteal orbital abscess in children: diagnosis, microbiology, and management. Laryngoscope (1993) 0.97
[Colonic retro-rectal depression by perineal colostomy in the treatment of acquired megacolon. Modified Duhamel's operation]. Rev Assoc Med Bras (1965) 0.95
Mechanism-based inhibition of zinc proteases. Curr Med Chem (2001) 0.93
Paediatric and congenital heart disease in South America: an overview. Heart (2009) 0.93
Results of transvenous occlusion of secundum atrial septal defects with the fourth generation buttoned device: comparison with first, second and third generation devices. International Buttoned Device Trial Group. J Am Coll Cardiol (2000) 0.92
Hospital-acquired bronchopulmonary infection in premature infants due to Branhamella catarrhalis. J Hosp Infect (1986) 0.89
Spontaneous rupture of a solitary nonparasitic cyst of the liver. Case report. Acta Chir Scand (1988) 0.89
[Use of forceps in the extraction of foreign bodies from the rectum]. Rev Paul Med (1971) 0.88
Absorption, dosage, and effect on mineral homeostasis of 25-hydroxycholecalciferol in premature infants: comparison with 400 and 800 IU vitamin D2 supplementation. J Pediatr (1985) 0.88
The concept of quasi-tissue-equivalent nanodosimeter based on the glow peak 5a/5 in LiF:Mg,Ti (TLD-100). Australas Phys Eng Sci Med (2003) 0.87
Free radical production by antibiotic-killed bacteria in the guinea pig middle ear. Laryngoscope (2001) 0.87
Insight into the complex and dynamic process of activation of matrix metalloproteinases. J Am Chem Soc (2001) 0.86
Neonatal nasal deformities secondary to nasal continuous positive airway pressure. Laryngoscope (1994) 0.86
Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. J Heart Lung Transplant (1998) 0.86
Placental site trophoblastic tumours and the concept of fertility preservation. BJOG (2011) 0.86
Identification of colchicine in placental blood from patients using herbal medicines. Chem Res Toxicol (2001) 0.86
Recognition of aminoglycoside antibiotics by enterococcal-staphylococcal aminoglycoside 3'-phosphotransferase type IIIa: role of substrate amino groups. Antimicrob Agents Chemother (1996) 0.85
Inhibition of the broad spectrum nonmetallocarbapenamase of class A (NMC-A) beta-lactamase from Enterobacter cloacae by monocyclic beta-lactams. J Biol Chem (1999) 0.84
Structural insight into the binding motifs for the calcium ion and the non-catalytic zinc in matrix metalloproteases. Bioorg Med Chem Lett (1998) 0.84
Health status response of rheumatoid arthritis to treatment with DAB486IL-2. Arthritis Care Res (1996) 0.83
[Experimental and clinical study on the use as a transplant of homogenous dura mater preserved in glycerin at room temperature]. AMB Rev Assoc Med Bras (1971) 0.83
Evidence of oxygen radical injury in experimental otitis media. Laryngoscope (1994) 0.83
Herpes laryngitis and tracheitis causing respiratory distress in a neonate. Arch Otolaryngol Head Neck Surg (1993) 0.83
Evidence of oxygen free radical damage in human otitis media. Otolaryngol Head Neck Surg (1999) 0.82
Tethered bisubstrate derivatives as probes for mechanism and as inhibitors of aminoglycoside 3'-phosphotransferases. J Org Chem (2000) 0.82
Control of mineral homeostasis during lactation: interrelationships of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, 1,25-dihydroxyvitamin D, parathyroid hormone, calcitonin, prolactin, and estradiol. Am J Obstet Gynecol (1981) 0.81
Purification of recombinant pp60v-src protein tyrosine kinase and phosphorylation of peptides with different secondary structure preference. Biochemistry (1989) 0.81
Penetration of cefprozil into middle ear fluid of patients with otitis media. Antimicrob Agents Chemother (1994) 0.81
Stereoselective reduction of alpha-bromopenicillanates by tributylphosphine. Org Lett (2000) 0.80
Mineral homeostasis in very premature infants: serial evaluation of serum 25-hydroxyvitamin D, serum minerals, and bone mineralization. J Pediatr (1985) 0.80
The use of neamine as a molecular template: inactivation of bacterial antibiotic resistance enzyme aminoglycoside 3'-phosphotransferase type IIa. Bioorg Med Chem Lett (1998) 0.79
Pervasive developmental delay in children presenting as possible hearing loss. Laryngoscope (1999) 0.79
Osteoporosis and hip fracture in a young woman with anorexia nervosa. Clin Orthop Relat Res (1986) 0.79
[Septic shock caused by Klebsiella oxytoca after colonoscopy]. Gastroenterol Clin Biol (1994) 0.79
Colostomy treatment of traumatic injuries of the large intestine: a system of management. Dis Colon Rectum (1974) 0.78
The first mechanism-based inactivators for angiotensin-converting enzyme. J Med Chem (1992) 0.78
Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases. Arch Immunol Ther Exp (Warsz) (1999) 0.78
Serum lipid profiles with and without CAD: Jordan Hyperlipidaemia and Related Targets Study (JoHARTS-1). East Mediterr Health J (2008) 0.78
Heat shock proteins in acute otitis media. Laryngoscope (1995) 0.78
Humor judgments as a function of identification classes: Canadian vs. American. J Psychol (1973) 0.77
Hydrogen peroxide in acute otitis media in guinea pigs. Laryngoscope (1997) 0.77
Middle ear catalase distribution in an animal model of otitis media. Eur Arch Otorhinolaryngol (1996) 0.77
A light-inactivated antibiotic. J Med Chem (2000) 0.77
Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis? Curr Oncol (2008) 0.77
Polymicrogyria in standard poodles. J Vet Intern Med (2009) 0.77
Properties of analogues of an intermediate in the process of mechanism-based inactivation of carboxypeptidase A. Bioorg Med Chem (1996) 0.76
Treatment of acquired megacolon by retrorectal lowering of the colon with a perineal colostomy: modified Duhamel operation. Dis Colon Rectum (1970) 0.76
[Sexual changes after surgical treatment of congenital acquired megacolon]. AMB Rev Assoc Med Bras (1969) 0.76
[Branhamella catarrhalis in neonatal pulmonary infectious pathology]. Pediatrie (1986) 0.76
Vitamin D deficiency and insufficiency in Africa and the Middle East, despite year-round sunny days. S Afr Med J (2015) 0.76
From genes to sequences to antibiotics: prospects for future developments from microbial genomics. Microbes Infect (2000) 0.76
Clinical presentation and outcome of cats with circumcaval ureters associated with a ureteral obstruction. J Vet Intern Med (2014) 0.76
Conjoint molecules of cephalosporins and aminoglycosides. Arch Pharm (Weinheim) (2001) 0.76
Inhibition of beta-lactamases by 6,6-bis(hydroxylmethyl)penicillanate. Bioorg Chem (2001) 0.76
[Transplacental passage of acyclovir]. Presse Med (1987) 0.76
[CHARGE association: new associated anomalies]. Arch Pediatr (1997) 0.75
Isolated fetal bilateral radial ray reduction associated with valproic acid usage. Fetal Diagn Ther (1994) 0.75
Competency-based training of health professions teachers in seven developing countries. Am J Public Health (1979) 0.75